| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.55M | 18.27M | 16.16M | 11.68M | 8.92M | 6.94M |
| Gross Profit | 599.00K | 13.25M | 10.19M | 5.75M | 3.54M | -559.00K |
| EBITDA | 2.95M | 4.82M | 1.36M | -265.00K | 172.00K | 772.00K |
| Net Income | -2.79M | -329.00K | -2.37M | -1.41M | -1.15M | -2.08M |
Balance Sheet | ||||||
| Total Assets | 38.62M | 38.10M | 34.39M | 23.62M | 11.76M | 13.58M |
| Cash, Cash Equivalents and Short-Term Investments | 4.80M | 8.57M | 15.39M | 1.99M | 1.46M | 2.74M |
| Total Debt | 11.87M | 10.80M | 9.13M | 18.72M | 0.00 | 7.08M |
| Total Liabilities | 18.23M | 16.70M | 12.71M | 22.69M | 9.27M | 9.33M |
| Stockholders Equity | 20.39M | 21.39M | 21.68M | 928.00K | 2.49M | 4.25M |
Cash Flow | ||||||
| Free Cash Flow | 2.68M | 1.57M | 1.42M | -142.00K | -438.00K | -507.00K |
| Operating Cash Flow | 2.71M | 2.94M | 2.63M | 308.00K | 134.00K | 212.00K |
| Investing Cash Flow | -9.70M | -7.97M | -5.28M | -8.72M | -575.00K | -842.00K |
| Financing Cash Flow | -897.00K | -1.79M | 16.05M | 8.94M | -708.00K | 2.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £280.23M | -0.96 | -12.22% | 15.28% | -3.91% | -310.36% | |
58 Neutral | £33.74M | 10.45 | 42.23% | 2.00% | -12.04% | ― | |
54 Neutral | £327.84M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% | |
52 Neutral | £59.49M | -17.61 | -13.36% | ― | 16.13% | -700.00% | |
41 Neutral | £320.89M | -2.81 | -142.88% | ― | -4.87% | ― |